Cargando…
Deficiency of superoxide dismutase promotes cerebral vascular hypertrophy and vascular dysfunction in hyperhomocysteinemia
There is an emerging consensus that hyperhomocysteinemia is an independent risk factor for cerebral vascular disease and that homocysteine-lowering therapy protects from ischemic stroke. However, the mechanisms by which hyperhomocysteinemia produces abnormalities of cerebral vascular structure and f...
Autores principales: | Dayal, Sanjana, Baumbach, Gary L., Arning, Erland, Bottiglieri, Teodoro, Faraci, Frank M., Lentz, Steven R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393600/ https://www.ncbi.nlm.nih.gov/pubmed/28414812 http://dx.doi.org/10.1371/journal.pone.0175732 |
Ejemplares similares
-
Protective Vascular and Cardiac Effects of Inducible Nitric Oxide Synthase in Mice with Hyperhomocysteinemia
por: Dayal, Sanjana, et al.
Publicado: (2014) -
Memantine Protects From Exacerbation of Ischemic Stroke and Blood Brain Barrier Disruption in Mild But Not Severe Hyperhomocysteinemia
por: Gu, Sean X., et al.
Publicado: (2020) -
Nox2 Deficiency Prevents Hypertension-Induced Vascular Dysfunction and Hypertrophy in Cerebral Arterioles
por: Chan, Siu-Lung, et al.
Publicado: (2013) -
Hyperhomocysteinemia Potentiates Hyperglycemia-Induced Inflammatory Monocyte Differentiation and Atherosclerosis
por: Fang, Pu, et al.
Publicado: (2014) -
Pharmacological induction of vascular extracellular superoxide dismutase expression in vivo
por: Oppermann, Marc, et al.
Publicado: (2009)